Marilia Barreca
Palermo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
A critical analysis on ENaC inhibitors, unravelling molecular medicinal insights and promising research roadmap in the treatment of cystic fibrosis.
Journal: European journal of medicinal chemistry
Published: February 27, 2026
Microwave-Enhanced Synthesis of 2-Styrylquinoline-4-Carboxamides With Promising Anti-Lymphoma Activity.
Journal: Archiv der Pharmazie
Published: July 31, 2025
Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis.
Journal: European journal of medicinal chemistry
Published: July 09, 2025
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction.
Journal: Angewandte Chemie (International ed. in English)
Published: April 11, 2025
In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors.
Journal: Journal of molecular graphics & modelling
Published: February 13, 2025
Citrus wastewater as a source of value-added products: Quali-quantitative analysis and in vitro screening on breast cancer cell lines.
Journal: Archiv der Pharmazie
Published: July 01, 2024
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis.
Journal: European journal of medicinal chemistry
Published: June 28, 2024
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis.
Journal: European journal of medicinal chemistry
Published: June 12, 2024
New strategies to hit hematological cancers.
Journal: European journal of medicinal chemistry
Published: April 06, 2024
Advances in developing noncovalent small molecules targeting Keap1.
Journal: Drug discovery today
Published: August 18, 2023
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
Journal: British journal of haematology
Published: July 10, 2023
Editorial: Emerging heterocycles as bioactive compounds.
Journal: Frontiers in chemistry
Published: April 07, 2023
Last Updated: 09/26/2026